Cargando…

Defining the effects of age and gender on clinical immune response to cancer vaccination

Detalles Bibliográficos
Autores principales:	Ramirez, Adriana, Wages, Nolan, Smolkin, Mark E, Slingluff, Craig L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288702/ http://dx.doi.org/10.1186/2051-1426-2-S3-P59

Ejemplares similares

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes
por: Dillon, Patrick M, et al.
Publicado: (2013)

Antibody response to melanoma helper-peptide vaccine correlates with survival
por: Olson, Walter C, et al.
Publicado: (2013)

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
por: Slingluff, Craig L, et al.
Publicado: (2014)

TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
por: Mauldin, Ileana S, et al.
Publicado: (2014)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
por: Melssen, Marit M., et al.
Publicado: (2019)

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
por: Morgan, C, et al.
Publicado: (2012)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma
por: Patel, Sapna P, et al.
Publicado: (2021)

Difficulties with defining diagnostic accuracy study outcomes
por: Banister, Katie, et al.
Publicado: (2015)

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
por: Tebas, P, et al.
Publicado: (2012)

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes
por: Saubi, N, et al.
Publicado: (2009)

A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer
por: Katz, Matthew, et al.
Publicado: (2015)

Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
por: Frey, Reiner, et al.
Publicado: (2013)

Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD
por: Boldingh, AM, et al.
Publicado: (2011)

Seasonal and age-related variations impacting HPV vaccination uptake in Romania
por: Streinu-Cercel, Oana, et al.
Publicado: (2013)

Tissue-aggressive inflammatory response defines the tissue aggressiveness of the post-infarction milieu
por: Grins, E, et al.
Publicado: (2014)

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013)

Evaluation of early immune response in multitrauma patients admitted in ICU: the effect of age
por: Markopoulou, D, et al.
Publicado: (2015)

The viral vector vaccine VSV-GP boosts immune response upon repeated applications
por: Tober, R, et al.
Publicado: (2012)

Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis
por: Schaefer , Jochen T, et al.
Publicado: (2010)

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes
por: Dillon, Patrick M, et al.
Publicado: (2014)

Self-adjuvanted RNActive(® )vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

Immune responses triggered by HIV/AIDS vaccine candidates, derived from MVA-B, with deletions in several immune regulatory genes
por: García-Arriaza, J, et al.
Publicado: (2012)

HPV vaccination in HIV+ adolescents and young adults induces strong HPV-specific immune responses
por: Rainone, V, et al.
Publicado: (2014)

Previously defined 53 immune gene panel predicts melanoma survival using The Cancer Genome Atlas (TCGA)
por: Gartrell, Robyn, et al.
Publicado: (2015)

Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
por: Liao, John B, et al.
Publicado: (2014)

In vitro SIV replication kinetics correlate with vaccine induced cellular immune responses and predict post-challenge outcome in immunized rhesus macaques
por: Ochieng, Washingtone, et al.
Publicado: (2006)

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)
por: Slingluff, Jr., Craig L, et al.
Publicado: (2021)

Immunologic hierarchy and promiscuity of melanoma helper peptides
por: Hu, Yinin, et al.
Publicado: (2013)

Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates
por: Bliss, Carly M, et al.
Publicado: (2014)

Xanthan gum enhances humoral immune response elicited by a DNA vaccine against leptospirosis in mice
por: Silveira, Marcelle, et al.
Publicado: (2014)

Enhancement of potent immune responses to HPV16 E7 antigen by using different vaccine modalities
por: Bolhassani, Azam, et al.
Publicado: (2011)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, PF, et al.
Publicado: (2012)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
por: van Montfort, Thijs, et al.
Publicado: (2011)

Age and gender dependence of pre-contrast T1-relaxation times in normal human myocardium at 1.5T using ShMOLLI
por: Piechnik, Stefan K, et al.
Publicado: (2012)

Defining the effects of prematurity on the lymphocyte transcriptome
por: Bhattacharya, Soumyaroop, et al.
Publicado: (2014)

Failure to define level 1 care
por: Fletcher, B, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cjo06914gi57jo6b05okjh9vr0